Teva Pharma Valuation
| TEVA Stock | USD 16.10 0.14 0.86% |
At this time, the company appears to be overvalued. Teva Pharma Industries has a current Real Value of $14.62 per share. The regular price of the company is $16.1. Our model measures the value of Teva Pharma Industries from inspecting the company fundamentals such as Operating Margin of 0.21 %, return on equity of -0.28, and Shares Outstanding of 1.15 B as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Teva Pharma's valuation include:
Price Book 3.4335 | Enterprise Value | Enterprise Value Ebitda 42.916 | Price Sales 1.1272 | Forward PE 6.2035 |
Overvalued
Today
Please note that Teva Pharma's price fluctuation is not too volatile at this time. Calculation of the real value of Teva Pharma Industries is based on 3 months time horizon. Increasing Teva Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Teva Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Teva Stock. However, Teva Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.1 | Real 14.62 | Target 24.17 | Hype 16.1 |
The real value of Teva Stock, also known as its intrinsic value, is the underlying worth of Teva Pharma Industries Company, which is reflected in its stock price. It is based on Teva Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Teva Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Teva Pharma Industries helps investors to forecast how Teva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Teva Pharma more accurately as focusing exclusively on Teva Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Teva Pharma's intrinsic value based on its ongoing forecasts of Teva Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Teva Pharma's closest peers. If more than one evaluation category is relevant for Teva Pharma we suggest using both methods to arrive at a better estimate.
Teva Pharma Cash |
|
Teva Valuation Trend
Comparing Teva Pharma's enterprise value against its market capitalization is a good way to estimate the value of Teva Pharma Industries uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Teva Revenue by Product
Teva Pharma Total Value Analysis
Teva Pharma Industries is at this time anticipated to have valuation of 33.35 B with market capitalization of 18.65 B, debt of 18.08 B, and cash on hands of 2.22 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Teva Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.35 B | 18.65 B | 18.08 B | 2.22 B |
Teva Pharma Investor Information
About 60.0% of the company shares are owned by institutional investors. The book value of Teva Pharma was at this time reported as 4.74. The company has Price/Earnings To Growth (PEG) ratio of 0.97. Teva Pharma Industries recorded a loss per share of 1.45. The entity last dividend was issued on the 27th of November 2017. The firm had 2:1 split on the 1st of July 2004. Based on the key measurements obtained from Teva Pharma's financial statements, Teva Pharma Industries is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.9 B | 1.2 B |
|
|
Teva Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Teva Pharma has an asset utilization ratio of 42.07 percent. This suggests that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that Teva Pharma Industries is more efficient with each dollar of assets it utilizes for everyday operations.Teva Pharma Ownership Allocation
Teva Pharma Industries shows a total of 1.15 Billion outstanding shares. Over half of Teva Pharma's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Teva Pharma Profitability Analysis
The company reported the previous year's revenue of 16.54 B. Net Loss for the year was (1.96 B) with profit before overhead, payroll, taxes, and interest of 8.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Teva Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Teva Pharma and how it compares across the competition.
About Teva Pharma Valuation
The stock valuation mechanism determines Teva Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Teva Pharma. We calculate exposure to Teva Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Teva Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 8.1 B | 4.9 B | |
| Pretax Profit Margin | (0.08) | (0.07) | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.10) | (0.09) | |
| Gross Profit Margin | 0.49 | 0.38 |
Teva Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.1 B | |
| Quarterly Earnings Growth Y O Y | 0.4 | |
| Forward Price Earnings | 6.2035 |
Teva Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Teva Pharma Industries and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Teva we look at many different elements of the entity such as Teva's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Teva Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Teva Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Teva Pharma's worth.Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |